Back to search

Article

The efficacy and safety of pyrotinib in treating HER2-positive metastatic breast cancer patients:A multi-center study

2023-12-28

Abstract excerpt

<title>Abstract</title> <p><bold>Purpose: </bold>To investigate the efficacy and safety of pyrotinib in treating patients with HER2-positive metastatic breast cancers (MBC). <bold>Patients and Methods: </bold>We performed a multi-center retrospective study, and the HER2-positive MBC patients were recruited. The progression-free survival (PFS), and overall survival (OS) were considered in the assessment of treatme...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3f21c983-1be2-5dbf-b82d-90dde6ba1d4e
DOI
10.21203/rs.3.rs-3670277/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The efficacy and safety of pyrotinib in treating HER2-positive metastatic breast cancer patients:A multi-center studyDOI 10.21203/rs.3.rs-3670277/v1
Alpelisib Exhibits a Synergistic Effect with Pyrotinib and Reverses Acquired Pyrotinib Resistance in HER2+ Breast CancerSemantic proximity
Real-world data of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer centerSemantic proximity
The Present and Future of Clinical Management in Metastatic Breast CancerSemantic proximity
A retrospective study of first-line therapy and subsequent pyrotinib treatment in advanced lung adenocarcinoma with HER2 mutations.Semantic proximity
Comparison of Targeted Therapy Efficacy in HER2-Positive Versus HER2-Negative Breast Cancer PatientsSemantic proximity
A systematic review and meta-analysis of nab-paclitaxel mono-chemotherapy for metastatic breast cancerSemantic proximity
Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial.Semantic proximity
Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations: a phase II study.Semantic proximity
A Systematic Review and Meta-Analysis of Nab-Paclitaxel Mono-Chemotherapy for Metastatic Breast Cancer.Semantic proximity
Dramatic Response to Pyrotinib and T-DM1 in HER2-Negative Metastatic Breast Cancer With 2 Activating HER2 Mutations.Semantic proximity
Molecular landscape and efficacy of HER2-targeted therapy in patients with HER2-mutated metastatic breast cancerSemantic proximity
Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real‐world databaseSemantic proximity
Select a neighboring publication to make it the new centre.